scholarly journals Verrucous mass of the leg in an octogerian woman

Author(s):  
Mariem Rekik ◽  
Khadija Sellami ◽  
mariem Amouri ◽  
Saadia Makni ◽  
Naourez Gouiaa ◽  
...  

Various clinical forms of cutaneous leishmaniasis can be encountered such as: ulcerated, lupoïd, sporotrichoïd and other rare forms (eczematiform, erysipeloid, psoriasiform, verrucous, and pseudotumoral). We report an atypical presentation. Dermatologists should be aware when facing a verrucous mass, especially if the patient comes from an endemic country.

Parasitology ◽  
2012 ◽  
Vol 140 (1) ◽  
pp. 29-38 ◽  
Author(s):  
F. M. AMORIM ◽  
Y. K. S. RODRIGUES ◽  
T. P. BARBOSA ◽  
P. L. N. NÉRIS ◽  
J. P. A. CALDAS ◽  
...  

SUMMARYCurrent treatments for different clinical forms of leishmaniasis are unsatisfactory, highly toxic and associated with increasing failure rates resulting from the emergence of resistant parasites. Leishmania (Viannia) braziliensis is the main aetiological agent of different clinical forms of American tegumentary leishmaniasis, including the mucosal form for which treatment has high failure rates. The aim of this work was to investigate the activity of the Morita-Baylis-Hillman adduct, methyl 2-{2-[hydroxy(2-nitrophenyl)methyl])acryloyloxy} benzoate in vitro against isolates of L. (V.) braziliensis obtained from patients with different clinical manifestations of tegumentary leishmaniasis: localized cutaneous leishmaniasis, mucosal leishmaniasis and disseminated cutaneous leishmaniasis. The adduct effectively inhibited the growth of promastigotes of the different isolates of L. (V.) braziliensis (IC50 ⩽ 7·77 μg/ml), as well as reduced the infection rate of macrophages infected with these parasites (EC50 ⩽ 1·37 μg/ml). It is remarkable to state that the adduct was more effective against intracellular amastigotes (P ⩽ 0·0045). The anti-amastigote activity correlated with an immunomodulatory effect, since the adduct was able to decrease the production of IL-6 and IL-10 by the infected macrophages. However, its effect was independent of nitric oxide production. This work demonstrates the anti-leishmanial activity of methyl 2-{2-[hydroxy(2-nitrophenyl)methyl])acryloyloxy} benzoate and suggests its potential in the treatment of human infections caused by L. (V.) braziliensis.


2013 ◽  
Vol 33 (2) ◽  
pp. 187-191 ◽  
Author(s):  
Soumaya Yaich ◽  
Khaled Charfeddine ◽  
Abderrahmen Masmoudi ◽  
Mondher Masmoudi ◽  
Sawssen Zaghdhane ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-5
Author(s):  
Guilherme Almeida Rosa da Silva ◽  
Daniel Sugui ◽  
Rafael Fernandes Nunes ◽  
Karime de Azevedo ◽  
Marcelo de Azevedo ◽  
...  

Leishmaniasis is an infectious disease that is endemic in tropical areas and in the Mediterranean. This condition spreads to 98 countries in four continents, surpassing 12 million infected individuals, with 350 million people at risk of infection. This disease is characterized by a wide spectrum of clinical syndromes, caused by protozoa of the genusLeishmania, with various animal reservoirs, such as rodents, dogs, wolves, foxes, and even humans. Transmission occurs through a vector, a sandfly of the genusLutzomyia. There are three main clinical forms of leishmaniasis: visceral leishmaniasis, cutaneous leishmaniasis, and mucocutaneous leishmaniasis. The wide spectrum of nonvisceral forms includes: localized cutaneous leishmaniasis, a papular lesion that progresses to ulceration with granular base and a large framed board; diffuse cutaneous leishmaniasis; mucocutaneous leishmaniasis, which can cause disfiguring and mutilating injuries of the nasal cavity, pharynx, and larynx. Leishmaniasis/HIV coinfection is considered an emerging problem in several countries, including Brazil, where, despite the growing number of cases, a problem of late diagnosis occurs. Clinically, the cases of leishmaniasis associated with HIV infection may demonstrate unusual aspects, such as extensive and destructive lesions. This study aims to report a case of mucocutaneous leishmaniasis/HIV coinfection with atypical presentation of diffuse desquamative eruption and nasopharyngeal involvement.


2020 ◽  
Vol 2020 (8) ◽  
Author(s):  
Sulafa Ahmad ◽  
Hamid Suleiman ◽  
Zuheir Al-Shehabi

ABSTRACT Lupoid cutaneous leishmaniasis (LCL) is a rare, atypical presentation of cutaneous leishmaniasis (CL). In this report, the authors present the case of a severe LCL in an elderly patient who presented to our dermatology department with severe, painful ulcerated lesion on his midface with cosmetic deformity to his nose. He had a history of CL 3 years ago at the same place. Histopathologic examination showed epidermal and dermal changes with chronic inflammatory infiltrate and no leishmaniasis bodies were detected. He was admitted and treated with systemic glucantime (60 mg/kg) for a month followed by hydroxychloroquine (200 mg twice a day) for another month with favorable outcome. Countries with endemic CL should consider LCL in patients with a history of leishmaniasis and a similar clinical presentation, especially that it could be misdiagnosed with other granulomatous cutaneous conditions, thus leading to cosmetic deformities that can be avoided with early adequate treatment.


2011 ◽  
Vol 56 (4) ◽  
pp. 428 ◽  
Author(s):  
RezaMahmoud Robati ◽  
Mehdi Qeisari ◽  
Mona Karimi ◽  
Marjan Saeedi

2020 ◽  
Vol 132 (1-2) ◽  
pp. 47-49 ◽  
Author(s):  
Edwin Kniha ◽  
Julia Walochnik ◽  
Wolfgang Poeppl ◽  
Gerhard Mooseder ◽  
Adelheid G. Obwaller

SummaryLeishmaniasis is a severe vector-borne disease with two main clinical forms, visceral leishmaniasis and cutaneous leishmaniasis. Both forms of leishmaniasis are also endemic in Mediterranean countries including the Balkan region from where mainly visceral leishmaniasis is reported. Austrian soldiers returning from Kosovo were screened for anti-Leishmania antibodies to assess the risk of infection during operations. Anti-Leishmania antibodies were detected in more than 20% of the soldiers investigated, which indicates a considerable risk of infection during missions in this area and thus suggests the application of protective measures.


2013 ◽  
Vol 19 ◽  
pp. 226-231 ◽  
Author(s):  
Ahmad Oryan ◽  
Sadegh Shirian ◽  
Mohammad-Reza Tabandeh ◽  
Gholam-Reza Hatam ◽  
Gerrit Randau ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document